Medici List crest
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Arrive AI Inc.

CIK: 18182741 Annual ReportLatest: 2026-04-15

10-K / April 15, 2026

Arrive AI Inc.

What the company does

Arrive AI is an early-stage technology company building infrastructure and a platform for Autonomous Last Mile (ALM) delivery using drones and robotic systems. Its core offering is the Arrive Point™ network — a set of smart lockers and mini-cross-docks that enable secure, asynchronous exchange of packages among people, drones/robots, delivery providers, retailers, and consumers.

Platform and products

  • Arrive Point Network (Network-as-a-Service): smart locker and mini-cross-dock locations providing secure exchange, temperature control options, and chain-of-custody features.
  • ALM Marketplace: dynamic scheduling, pricing, and space optimization across the network.
  • AI Services: edge computing on AP4/AP5 devices and analytics for reverse logistics, routing density/arbitrage, growth forecasting, and device-level human interactions.
  • Product generations: multi-generational Arrive Points (AP3, AP4, AP5) designed for compatibility with major drone and robotic systems and equipped for secure custody and temperature-controlled handling.

Business model

The company’s revenue approach has three pillars:

  1. Arrive Point Network (Network-as-a-Service): subscription fees (monthly/annual), plus installation, support, and maintenance revenue.
  2. AI Services: monetization of transactional and environmental data through machine learning and analytics.
  3. ALM Marketplace: dynamic pricing and space optimization transactions across the network.

The five-year plan targets deployment of 100,000 Arrive Points, with revenue expected to be roughly split between Network-as-a-Service and Marketplace & AI Services.

Market approach and traction

  • Initial commercial focus on medical and logistics customers, with pilot programs conducted with a regional hospital and a specialty pharmaceutical delivery company.
  • Commercial operations began in 2025.

Key operating details

  • Headquarters: Fishers, Indiana. The company leases approximately 30,000 square feet of office/industrial space from a related party under a lease through 2030.
  • Employees: 41 full-time employees as of December 31, 2025, and about 10 part-time contract employees.
  • Commercial activity: began in 2025; reported revenue of $113,250 for the 12 months ended December 31, 2025.

Financial position and liquidity

  • Cash on hand: approximately $2.104 million as of December 31, 2025.
  • Operating cash flow: $(8,253,348) for the twelve months ended December 31, 2025; $(2,289,273) for the twelve months ended December 31, 2024.
  • Management has expressed substantial doubt about the company’s ability to continue as a going concern due to ongoing losses and cash burn. Planned sources of liquidity include existing cash, proceeds from a 2026 Streeterville financing, and potential additional drawdowns subject to conditions.

Intellectual property

  • Exclusive Patent License Agreement with CEO Daniel S. O’Toole, amended in December 2024 and March 2025, granting rights to use, sell, manufacture, and commercialize certain ALM mailbox technologies.
  • The business relies heavily on the licensed technology from the CEO.
  • Patent portfolio: nine U.S. patents issued as of December 31, 2025; three additional U.S. patent applications pending examination; 77 non-U.S. patent applications in process, with several international patents and pending national phases.

Trademarks and software

  • Trademark activity includes DRONEDEK and ARRIVE-related marks, with several marks registered or allowed and ongoing filings for the ARRIVE family and related terms.
  • The company uses third-party and open-source software components and acknowledges associated compliance obligations and risks.

Customers and traction

  • Pilot programs with at least two customers: a regional hospital and a specialty pharmaceutical delivery company.
  • Early commercial activity and pilot deployments serve as initial validation for the platform.

Regulatory, safety, and compliance considerations

  • Data privacy and protection requirements are a focus (e.g., CCPA/CPRA, Virginia DP Act) and HIPAA applies when handling protected health information in early operations.
  • Evolving AI-related regulation may affect product development and deployment.
  • Drone and robotic delivery face regulatory requirements for airspace access, safety, and privacy.
  • Environmental, health, and safety considerations apply to hardware development and testing, including hazardous materials handling in R&D and manufacturing.

Notable risks and governance

  • Early-stage, loss-making profile with ongoing capital needs.
  • Dependence on management, particularly the CEO, for intellectual property and capital-raising.
  • Financing arrangements with Streeterville Capital include provisions that could trigger substantial monthly cash repayments under certain conditions; outcomes are linked to stock price and market conditions.
  • As of March 31, 2026, the company was not in compliance with certain Nasdaq continued listing standards, creating potential delisting risk and related implications for liquidity and funding.
  • Material weaknesses in internal controls have been identified and remediation efforts are underway.
  • Ongoing litigation includes an employment action and contract/loan-related matters.

Public-company status

Arrive AI operates as an emerging growth company and a smaller reporting company, and has used related exemptions for certain internal control attestation and disclosure requirements.

Summary

Arrive AI is developing a universal ALM infrastructure and platform centered on Arrive Points, with revenue channels from network subscriptions, AI/analytics services, and marketplace transactions. The company began commercial operations in 2025, reported modest revenue in that year, is in an early-stage loss-making phase, and intends to scale its network to 100,000 Arrive Points over five years while managing IP, funding, regulatory, and governance risks.